François Laliberté

Publication Activity (10 Years)

Years Active: 2018-2022
Publications (10 Years): 14

Top Topics

Venous Thromboembolism

Atrial Fibrillation

Peripheral Artery Disease

Top Venues

Journal of medical economics

The Journal of asthma : official journal of the Association for the Care of Asthma

Journal of thrombosis and thrombolysis

Future oncology (London, England)

This page only lists publications with an associated author ORCID identifier.

Publications

David Mannino, Michael Bogart, Guillaume Germain, Shirley P Huang, Afisi S Ismaila, François Laliberté, Young Jung, Sean D MacKnight, Marjorie A Stiegler, Mei Sheng Duh
Benefit of Prompt versus Delayed Use of Single-Inhaler Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) Following a COPD Exacerbation. International journal of chronic obstructive pulmonary disease 17 (2022)
Jeffrey S Berger, François Laliberté, Akshay Kharat, Dominique Lejeune, Kenneth Todd Moore, Young Jung, Patrick Lefebvre, Veronica Ashton
Effectiveness, safety, and healthcare costs associated with rivaroxaban versus warfarin among venous thromboembolism patients with obesity: a real-world study in the United States. Journal of thrombosis and thrombolysis 54 (3) (2022)
Jeffrey S Berger, François Laliberté, Akshay Kharat, Dominique Lejeune, Kenneth Todd Moore, Young Jung, Patrick Lefebvre, Veronica Ashton
Healthcare resource utilization and costs of rivaroxaban versus warfarin among non-valvular atrial fibrillation (NVAF) patients with obesity in a US population. Journal of medical economics 24 (1) (2021)
Neal D Shore, Raluca Ionescu-Ittu, Lingfeng Yang, François Laliberté, Malena Mahendran, Dominique Lejeune, Louise Yu, Joseph Burgents, Mei Sheng Duh, Sameer R Ghate
Real-world genetic testing patterns in metastatic castration-resistant prostate cancer. Future oncology (London, England) 17 (22) (2021)
Jeffrey S Berger, François Laliberté, Akshay Kharat, Dominique Lejeune, Kenneth Todd Moore, Young Jung, Patrick Lefebvre, Veronica Ashton
Real-world effectiveness and safety of rivaroxaban versus warfarin among non-valvular atrial fibrillation patients with obesity in a US population. Current medical research and opinion 37 (6) (2021)
Carlyne M Averell, François Laliberté, Guillaume Germain, Mei Sheng Duh, Robson Lima, Malena Mahendran, David J Slade
Symptom control in patients with asthma using inhaled corticosteroids/long-acting β2-agonists (fluticasone furoate/vilanterol or budesonide/formoterol) in the US: a retrospective matched cohort study. The Journal of asthma : official journal of the Association for the Care of Asthma (2021)
François Laliberté, Veronica Ashton, Akshay Kharat, Dominique Lejeune, Kenneth Todd Moore, Young Jung, Patrick Lefebvre, Jeffrey S Berger
Economic burden of rivaroxaban and warfarin among nonvalvular atrial fibrillation patients with obesity and polypharmacy. Journal of comparative effectiveness research 10 (16) (2021)
Xiaoqin Yang, François Laliberté, Guillaume Germain, Monika Raut, Mei Sheng Duh, Shuvayu S Sen, Dominique Lejeune, Kaushal Desai, Philippe Armand
Treatment patterns, healthcare resource utilization, and costs of patients diagnosed with primary mediastinal B-cell lymphoma in the United States. Journal of medical economics 24 (1) (2021)
Urvi Desai, Akshay A Kharat, Connie N Hess, Dejan Milentijevic, François Laliberté, Peter Zuckerman, John Benson, Patrick Lefebvre, William R Hiatt, Marc P Bonaca
Healthcare resource utilization and costs of major atherothrombotic vascular events among patients with peripheral artery disease after revascularization. Journal of medical economics 24 (1) (2021)
Jeffrey S Berger, François Laliberté, Akshay Kharat, Dominique Lejeune, Kenneth Todd Moore, Young Jung, Patrick Lefebvre, Veronica Ashton
Comparative Effectiveness and Safety of Rivaroxaban and Warfarin Among Nonvalvular Atrial Fibrillation (NVAF) Patients with Obesity and Polypharmacy in the United States (US). Advances in therapy 38 (7) (2021)
Carlyne M Averell, François Laliberté, Guillaume Germain, David J Slade, Mei S Duh, Joseph Spahn
Disease burden and treatment adherence among children and adolescent patients with asthma. The Journal of asthma : official journal of the Association for the Care of Asthma (2021)
Alok A Khorana, Nicole M Kuderer, Keith McCrae, Dejan Milentijevic, Guillaume Germain, François Laliberté, Sean D MacKnight, Patrick Lefebvre, Gary H Lyman, Michael B Streiff
Healthcare costs of patients with cancer stratified by Khorana score risk levels. Journal of medical economics 24 (1) (2021)
Alok A Khorana, Keith McCrae, Dejan Milentijevic, Nora McCormick, François Laliberté, Concetta Crivera, Patrick Lefebvre, Dominique Lejeune, Heather Rozjabek, Jeff Schein, Michael B Streiff
The risk of recurrent VTE and major bleeding in a commercially-insured population of cancer patients treated with anticoagulation. American journal of hematology 94 (2) (2018)
Philip Stephen Wells, Anthonie W A Lensing, Lloyd Haskell, Bennett Levitan, François Laliberté, Michael Durkin, Veronica Ashton, Yongling Xiao, Concetta Crivera, Dominique Lejeune, Jeff Schein, Patrick Lefebvre
Cost comparison of continued anticoagulation with rivaroxaban versus placebo based on the 1-year EINSTEIN-Extension trial efficacy and safety results. Journal of medical economics 21 (6) (2018)